LENZ Therapeutics GAAP EPS of -$1.02 beats by $0.04, revenue of $5.5M beats by $3.12M (LENZ:NASDAQ)
· seekingalpha.com
LENZ Therapeutics (LENZ) Q2 update: GAAP EPS beat, revenue surged, and VIZZ shows strong refills and prescriber uptake.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...